Drug Search Results
More Filters [+]

Flupirtine

Alternative Names: flupirtine, katadolon
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GLUN Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Germany | India | Lithuania | Portugal | Russia

Approved Indications: None

Known Adverse Events: None

Company: AWD
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Flupirtine

Countries in Clinic: China

Active Clinical Trial Count: 3

Highest Development Phases

Phase 1: Acute Pain|Spasm

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20131587

P1

Active, not recruiting

Acute Pain|Spasm

None

CTR20131588

P1

Active, not recruiting

Spasm|Acute Pain

None

CTR20131585

P1

Active, not recruiting

Spasm|Acute Pain

None

Recent News Events